Merck Animal Health offers a broad portfolio of veterinary solutions, including medicines, vaccines, and technologies, to promote sustainable growth in the aquaculture and conservation industries. View some of our key products below to see their availability by fish species.
|AQUAFLOR ®||Family of broad-spectrum, in-feed antibiotics for the treatment of bacterial diseases in fish cause by bacteria susceptible to florfenicol.||x||x||x|
|SLICE®||Feed premix for the treatment and prevention of infestations of all parasitic stages of sea lice (Lepeophtheirus sp. and Caligus sp.)||x|
|AQUI-S ®||Aquatic anesthetic that can be used in a dose-dependent manner to provide light sedation suitable for disease treatments and transport, or for full anesthesia for health checks.||x|
|AQUAVAC® STREP Sa-Si||Bivalent vaccine for the active immunization of susceptible fish species to reduce mortality and disease due to Streptococcosis caused by Streptococcus agalactiae (serotype Ib) and S. iniae.||x|
|AQUAVAC® RELERA||Inactivated, vaccine against Enteric Redmouth Disease (ERM) caused by Yersinia ruckeri biotype 1 and biotype 2 (Hagerman type 1 and EX5 biogroup) in rainbow trout.||x|
|AQUAVAC® IRIDO V||Vaccine for the active immunization of susceptible fish species, like tilapia and Asian sea bass, to reduce mortality due to Iridovirus||x||x|
|AQUAVAC® SARISTIN 2||Bivalent vaccine that stimulates active immunity in the prevention of Infectious Pancreatic Necrosis (IPN) and Salmonid Rickettsial Syndrome (SRS) caused by Piscirickettsia salmonis in salmonids.||x||x|
|AQUAVAC® 6||Hexavalent vaccine to reduce clinical signs and mortality from infections with Infectious Pancreatic Necrosis (IPN), Furunculosis, Vibriosis and Wound Disease in Atlantic salmon.||x|
|AQUAVAC® PD7||Heptavalent vaccine that stimulates active immunity in the prevention of Salmon Pancreas Disease (SPD), IPN, Furunculosis, Vibriosis and Wound Disease in Atlantic salmon.||x|
Click here for our complete Aquavac product guide.